2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee
Abstract

Research Snapshot Theater: Cardiovascular/Pharmacology, Adult I

Tuesday, March 24, 2026
8:45 AM - 9:45 AM Central Time
Location: Connections Central - RST 02

    RST Moderator(s)

  • David Porembka, DO, MCCM

    University of Maryland Medical Center, R. Adams Cowley Shock Trauma Center, Maryland

    Disclosure(s): No relevant financial relationship(s) to disclose.

  • RP

    Robier Prada, M.D.

    Associate Professor
    UT Health-Houston

    Disclosure information not submitted.

Presentations:

  • 8:45 AM - 9:45 AM Central Time
    Evaluation of Methylene Blue in Cardiothoracic Surgery-Related Vasoplegic Shock

    Ada Jutba, PharmD, BCCCP (she/her/hers) – MEMORIAL HERMANN MEMORIAL CITY HOSPITAL

    Valerie Nguyen, PharmD – Harris Health System

    Reagan Webber, PharmD – University Health System

    Maicuc Tran, PharmD, BCPS – Memorial Hermann Specialty Pharmacy

  • 8:45 AM - 9:45 AM Central Time
    Outcomes of Clopidogrel vs Potent P2Y12 Inhibitors in Patients With ACS and AF on OAC

    Makaylah Garrett, PharmD (she/her/hers) – IU Health Methodist Hospital

    Ryan Caputo, PharmD – Indiana University Health AAHC

  • 8:45 AM - 9:45 AM Central Time
    Diagnostic Scoring Tools for Heparin-Induced Thrombocytopenia in Mechanical Circulatory Support

    Michelle Dillon, PharmD, BCCCP – AdventHealth Orlando

    Alese Photiadis, PharmD – AdventHealth Orlando

    Danielle McPherson, PharmD, BCCP – AdventHealth Orlando

  • 8:45 AM - 9:45 AM Central Time
    Safety and Efficacy of Ketorolac Use After Coronary Artery Bypass Graft Surgery

    Jessica A. Ward, PharmD, BCCCP (she/her/hers) – Cleveland Clinic Foundation

    Ben Hohfelder, BCCCP, BCPS, PharmD – Cleveland Clinic Foundation

    Cheri Lober, PharmD – Cleveland Clinic Foundation

    A. Marc Gillinov, MD – Cleveland Clinic Foundation

    Steven Insler, MD (he/him/his) – Cleveland Clinic Foundation

  • 8:45 AM - 9:45 AM Central Time
    Cardiovascular Effects of Landiolol in Intensive Care Patients: A Retrospective Safety Analysis

    Dylan LECLERC, n/a

    Azrat Ibrahima, n/a – CHU Amiens Sud

    Yoann Zerbib, N/A – CHU Amiens Sud

    Louis Gibert, N/A – CHU Amiens Sud

    Christophe Beyls, N/A – CHU Amiens Sud

    Yazine Mahjoub, N/A – CHU Amiens Sud

    Clément Brault, N/A – CHU Amiens Sud

    Julien Maizel, MD-PHD – CHU Amiens Sud

    Michel Slama, MD-PHD – CHU Amiens Sud

  • 8:45 AM - 9:45 AM Central Time
    Outcomes of Epinephrine Versus Dobutamine and Norepinephrine for Septic Shock and Cardiomyopathy

    Samantha Camp, BS

  • 8:45 AM - 9:45 AM Central Time
    Characterization of Esmolol Use for Acute Aortic Syndrome at a Tertiary Academic Medical Center

    Sterling S. Baumgarten, PharmD

    Cassandra Baker, PharmD – VCU Health

  • 8:45 AM - 9:45 AM Central Time
    Esmolol Versus Labetalol in Acute Aortic Syndromes

    Kristina Jasnic, PharmD (she/her/hers) – Novant Health Forsyth Medical Center

    Abby Harris, PharmD, BCCCP, CPP – Novant Health Forsyth Medical Center

    Ryan Kammer, PharmD, BCPS, CPP – Novant Health Forsyth Medical Center

    Alexis Knoles, PharmD – Novant Health Forsyth Medical Center